arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

NRC Health

NRC Health Care Biotechnology: Commercial Physical & Biological Resarch
$21.59
Today
as of Jul 22, 16:52 ET
Last 30 days +17.91% Jun 15 → Jul 22
$17.35 $18.80 $20.26 $21.72 $23.17 Jun 15 Jun 23 Jun 30 Jul 08 Jul 15 Jul 22
Open
$19.87
High
$20.09
Low
$19.05
Volume
$152,167
Avg Vol
$101,416
Mkt Cap
$483M
P/E (TTM)
61.74
Beta
—
52w High
$22.79
52w Low
$11.01
Div Yield
—
Shares Out
$23M

Recent Press Releases & News last 60 days · 1 item

Jun 9 · 13:00 PR Business Wire
NRC Health and Healthcare Experience Foundation Launch Strategic Partnership to Deepen Support for Improving Experience, Safety, and Workforce Engagement

Overview

52-week range
$11
$23
90% of range
Avg surprise (last 0)
—
Avg reaction (last 1)
+1.1%
100% positive
Latest IV / EM
44%
EM ±10.1% · $23 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.14$0.18$0.23$0.28$0.32 Actual $0.29Actual $0.32Actual $0.27Actual $0.26Actual $0.24Actual $0.25Actual $0.28Actual $0.18Actual $0.14 JunSepMarJunSepMar/2025Jun/2025SepMar

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $0.14 — — — — financials
Tue Sep 30, 2025Sep 2025 $0.18 — — — — financials
Mon Jul 28, 2025Jun/2025 $0.28 — — — — earnings
Mon Apr 28, 2025Mar/2025 $0.25 — — — +1.1% earnings
Mon Sep 30, 2024Sep 2024 $0.24 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.26 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.27 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.32 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.29 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Mon Jul 27, 2026Jun/2026OTHER —$0.28

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$6M—$8M$2M$9M—$8M$9M
Net income————————
EPS (diluted)$0.14—$0.18$-0.01$0.25—$0.24$0.26

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$3M$4M$2M$5M$3M$4M$3M$485,000
Inventory————————
Total current assets$20M$20M$20M$25M$20M$20M$21M$17M
Total assets$135M$135M$136M$141M$135M$133M$132M$119M
Long-term debt$74M$75M$76M$77M$59M$58M$45M$26M
Total liabilities$121M$121M$121M$120M$106M$101M$97M$79M
Total equity$13M$14M$14M$21M$30M$31M$35M$40M

Implied volatility — last 90 days

28%79%130%180%231% Jun 07 — IV 49% · EM ±6.8%Jun 08 — IV 45% · EM ±5.9%Jun 09 — IV 40% · EM ±5.1%Jun 10 — IV 101% · EM ±12.0%Jun 11 — IV 123% · EM ±13.6%Jun 12 — IV 232% · EM ±23.7%Jun 15 — IV 147% · EM ±10.7%Jun 16 — IV 188% · EM ±11.1%Jun 17 — IV 108% · EM ±4.5%Jun 19 — IV 42% · EM ±9.3%Jun 22 — IV 39% · EM ±8.2%Jun 23 — IV 37% · EM ±7.5%Jun 24 — IV 39% · EM ±7.7%Jun 25 — IV 37% · EM ±7.3%Jun 26 — IV 43% · EM ±8.3%Jun 29 — IV 37% · EM ±6.6%Jun 30 — IV 40% · EM ±7.0%Jul 01 — IV 36% · EM ±6.0%Jul 02 — IV 32% · EM ±5.1%Jul 03 — IV 33% · EM ±5.1%Jul 06 — IV 29% · EM ±4.0%Jul 07 — IV 33% · EM ±4.4%Jul 08 — IV 40% · EM ±5.0%Jul 09 — IV 101% · EM ±12.0%Jul 10 — IV 82% · EM ±9.0%Jul 13 — IV 80% · EM ±6.6%Jul 14 — IV 72% · EM ±5.2%Jul 16 — IV 109% · EM ±4.6%Jul 20 — IV 45% · EM ±10.6%Jul 21 — IV 44% · EM ±10.2%Jul 22 — IV 44% · EM ±10.1%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in